These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15059648)

  • 1. The evidence-based treatment of AIDS-related non-Hodgkin's lymphoma.
    Stebbing J; Marvin V; Bower M
    Cancer Treat Rev; 2004 May; 30(3):249-53. PubMed ID: 15059648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
    Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
    Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modern management of non-Hodgkin lymphoma in HIV-infected patients.
    Mounier N; Spina M; Gisselbrecht C
    Br J Haematol; 2007 Mar; 136(5):685-98. PubMed ID: 17229246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
    Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
    Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-associated non-Hodgkin lymphoma: incidence, presentation, and prognosis.
    Little RF; Gutierrez M; Jaffe ES; Pau A; Horne M; Wilson W
    JAMA; 2001 Apr; 285(14):1880-5. PubMed ID: 11308402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma.
    Sawka CA; Shepherd FA; Franssen E; Brandwein J; Dotten DA; Routy JP; Walker IR; St-Louis J; Taylor M; Arts K; Crump M; Foote M
    Biotechnol Annu Rev; 2005; 11():381-9. PubMed ID: 16216784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
    Spina M; Simonelli C; Tirelli U
    J Clin Oncol; 2007 Feb; 25(6):e7. PubMed ID: 17308261
    [No Abstract]   [Full Text] [Related]  

  • 9. Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy.
    Thirlwell C; Sarker D; Stebbing J; Bower M
    Clin Lymphoma; 2003 Sep; 4(2):86-92. PubMed ID: 14556679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for HIV-associated non-Hodgkin's lymphoma.
    Newsom-Davis T; Ahamed E; Bower M
    Expert Opin Biol Ther; 2009 Oct; 9(10):1313-24. PubMed ID: 19645631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predominantly gastrointestinal symptoms and signs in 11 consecutive AIDS patients with gastrointestinal lymphoma: a multicenter, multiyear study including 763 HIV-seropositive patients.
    Cappell MS; Botros N
    Am J Gastroenterol; 1994 Apr; 89(4):545-9. PubMed ID: 8147357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated non-Hodgkin lymphoma: a pooled analysis of 15 prospective studies.
    Castillo JJ; Echenique IA
    Am J Hematol; 2012 Mar; 87(3):330-3. PubMed ID: 22308010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].
    Gabarre J; Bossi P
    Bull Cancer; 2003 May; 90(5):419-25. PubMed ID: 12850765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
    Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
    Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
    Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
    HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIDS-related non-Hodgkin's lymphoma in the first decade of highly active antiretroviral therapy.
    Palmieri C; Treibel T; Large O; Bower M
    QJM; 2006 Dec; 99(12):811-26. PubMed ID: 17085516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL).
    Rossi G; Donisi A; Casari S; Re A; Stellini R; Cadeo G; Carosi G
    Haematologica; 1998 Apr; 83(4):317-22. PubMed ID: 9592981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update in HIV lymphoma.
    Noy A
    Curr Opin Oncol; 2006 Sep; 18(5):449-55. PubMed ID: 16894292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Resistance avoided, prognosis improved--myocet in AIDS-related non-Hodgkin's lymphoma].
    Pohlmann BK
    Onkologie; 2004 Oct; 27(5):514-5. PubMed ID: 15595188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.